Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $545.71 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $140.23 | 7 | $0 (2024) |
| ABBVIE INC. | $68.07 | 4 | $0 (2024) |
| PFIZER INC. | $54.91 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $47.77 | 2 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $34.35 | 2 | $0 (2024) |
| Novo Nordisk Inc | $30.17 | 2 | $0 (2024) |
| Lilly USA, LLC | $25.43 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $20.39 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $19.71 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $19.64 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $432.31 | 23 | Amgen Inc. ($114.38) |
| 2023 | $113.40 | 6 | Amgen Inc. ($25.85) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/23/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Hyperthyroidism | ||||||
| 09/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: PAIN | ||||||
| 08/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Inflammation | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: VACCINE | ||||||
| 08/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Oncology | ||||||
| 07/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Inflammation | ||||||
| 03/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Inflammation | ||||||
| 02/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Inflammation | ||||||
| 12/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Inflammation | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 415 | 517 | $142,302 | $22,271 |
| 2022 | 7 | 388 | 481 | $167,788 | $20,437 |
| 2021 | 8 | 390 | 475 | $161,342 | $25,359 |
| 2020 | 6 | 282 | 329 | $78,248 | $10,355 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 324 | $95,983 | $14,330 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 117 | $23,828 | $4,713 | 19.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 17 | $9,775 | $959.54 | 9.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $6,882 | $879.44 | 12.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,512 | $535.82 | 35.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 13 | $2,665 | $523.93 | 19.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 16 | $1,657 | $329.68 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 217 | 280 | $106,219 | $11,783 | 11.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 120 | $32,346 | $4,770 | 14.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $9,847 | $1,644 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 24 | $12,264 | $1,261 | 10.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 17 | $4,554 | $637.04 | 14.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 14 | 14 | $2,283 | $279.06 | 12.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 11 | 11 | $275.00 | $62.36 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 168 | 220 | $85,770 | $13,911 | 16.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 132 | $36,128 | $5,492 | 15.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 20 | $10,900 | $2,042 | 18.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 36 | 41 | $11,267 | $1,600 | 14.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 12 | 12 | $7,356 | $1,198 | 16.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 14 | $5,474 | $634.47 | 11.6% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 24 | 25 | $4,161 | $428.58 | 10.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 11 | 11 | $286.00 | $51.93 | 18.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 96 | $31,488 | $4,311 | 13.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 112 | 138 | $31,188 | $3,684 | 11.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 44 | 47 | $6,439 | $705.99 | 11.0% |
About Nicole Morgan, PA-C
Nicole Morgan, PA-C is a Physician Assistant healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063425031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nicole Morgan, PA-C has received a total of $545.71 in payments from pharmaceutical and medical device companies, with $432.31 received in 2024. These payments were reported across 29 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($545.71).
As a Medicare-enrolled provider, Morgan has provided services to 1,475 Medicare beneficiaries, totaling 1,802 services with total Medicare billing of $78,422. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant, Medical
- Location Oldsmar, FL
- Active Since 08/14/2006
- Last Updated 10/05/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1063425031
Products in Payments
- Otezla (Drug) $140.23
- TRELEGY ELLIPTA (Drug) $47.77
- QULIPTA (Drug) $36.62
- VOQUEZNA (Drug) $34.35
- UBRELVY (Drug) $31.45
- MOUNJARO (Drug) $25.43
- PAXLOVID (Drug) $22.79
- Kerendia (Drug) $20.39
- BREZTRI (Drug) $19.71
- GARDASIL (Biological) $19.64
- REXULTI (Drug) $18.37
- Cologuard Collection Kit (Device) $17.41
- Rybelsus (Drug) $17.21
- NURTEC ODT (Drug) $17.02
- XIFAXAN (Drug) $16.40
- PREVNAR 20 (Biological) $15.10
- NP Thyroid 60 (Drug) $13.70
- Wegovy (Drug) $12.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Oldsmar
Jordin Ellingson, Pa-C, PA-C
Physician Assistant — Payments: $11,901
Clayton Noa, Pa, PA
Physician Assistant — Payments: $1,167
Julie Smith, Pa-C, PA-C
Physician Assistant — Payments: $1,141
Sean Worix, Pa-C, PA-C
Physician Assistant — Payments: $398.75
Nour Sayegh
Physician Assistant